Etanercept Biosimilar
Catalog #500027
| Cat # | Size | Price | Quantity | |
|---|---|---|---|---|
| 500027 | 1 mg | $200.00 | ||
| 500027 | 5 mg | $600.00 | ||
| 500027 | 20 mg | $1,250.00 |
Product Details
Anti-Human TNF (Etanercept Biosimilar) is a recombinant fusion protein that mimics the action of the natural tumor necrosis factor receptor (TNFR2). It consists of the extracellular domain of TNFR2 (p75) fused to the Fc region of human IgG1, allowing it to effectively bind and neutralize TNF-α, preventing its interaction with cell surface receptors. This biosimilar is widely used in inflammation, autoimmune disease, and immunology research.
Specifications
| Clone | Etanercept |
|---|---|
| Reactivities | Human |
| Isotype | Human IgG1 |
| Recommended Isotype Control | Human IgG1 isotype control |
| Format | Liquid |
| Formluation | PBS, pH 7.4 |
| Sterility | 0.2 µm filtered |
| Clonality | Recombinant |
| Conjugation | Unconjugated |
| Host | CHO cells |
| Purity | >95% (HPLC, SDS-PAGE) |
| Endotoxin | < 1.0 EU/mg (LAL assay) |
| Grade | In vivo ready (RUO) |
| Application | Neutralization; Flow Cytometry; ELISA; WB |
| Purification | Protein A |
| Storage Conditions | 2-8 °C, Avoid freeze / thaw cycle |
| Shelf Life | 6 months |
| Regulatory Status | RUO |